Department of Trauma and Orthopaedic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
European Calcified Tissue Society Clinical Practice Action Group, Brussels, Belgium.
JAMA Netw Open. 2024 Sep 3;7(9):e2432041. doi: 10.1001/jamanetworkopen.2024.32041.
Osteoporotic vertebral compression fractures (VCFs) frequently cause substantial pain and reduced mobility, posing a major health problem. Despite the critical need for effective pain management to restore functionality and improve patient outcomes, the value of various conservative treatments for acute VCF has not been systematically investigated.
To assess and compare different conservative treatment options in managing acute pain related to VCF.
On May 16, 2023, 4 databases-PubMed, Embase, Scopus, and CINAHL-were searched. In addition, a gray literature search within Scopus and Embase was also conducted.
Included studies were prospective comparative and randomized clinical trials that assessed conservative treatments for acute VCF.
Data extraction and synthesis were performed by 2 authors according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Network Meta-Analyses recommendations. A frequentist graph-theoretical model and a random-effects model were applied for the meta-analysis.
Primary outcomes were short-term (4 weeks) pain during activity and long-term (latest available follow-up) nonspecified pain in patients with acute VCF.
The study included 20 trials, encompassing 2102 patients, and evaluated various interventions for managing VCF. Calcitonin (standardized mean difference [SMD], -4.86; 95% CI, -6.87 to -2.86) and nonsteroidal anti-inflammatory drugs (NSAIDs; SMD, -3.94; 95% CI, -7.30 to -0.58) were beneficial regarding short-term pain during activity compared with placebo. For long-term nonspecific pain management, bisphosphonates were associated with inferior pain outcomes compared with daily (SMD, 1.21; 95% CI, 0.11 to 2.31) or weekly (SMD, 1.13; 95% CI, 0.05 to 2.21) administration of teriparatide, with no treatment being superior to NSAIDs. The qualitative analysis of adverse events highlighted that typical adverse events associated with these medications were observed.
NSAIDs and teriparatide may be the preferred treatment options for pain management in acute osteoporotic VCF. Although calcitonin also proved to be beneficial, its safety profile and potential adverse effects restrict its widespread application. The limited evidence on braces and analgesics underscores the urgent need for future research.
骨质疏松性椎体压缩性骨折(VCF)常引起严重疼痛和活动能力下降,是一个主要的健康问题。尽管有效管理疼痛以恢复功能和改善患者预后的需求迫切,但各种保守治疗急性 VCF 的价值尚未得到系统研究。
评估和比较管理急性 VCF 相关疼痛的不同保守治疗选择。
2023 年 5 月 16 日,检索了 4 个数据库 - PubMed、Embase、Scopus 和 CINAHL。此外,还在 Scopus 和 Embase 内进行了灰色文献搜索。
纳入的研究为评估急性 VCF 保守治疗的前瞻性比较和随机临床试验。
两名作者根据系统评价和荟萃分析的首选报告项目进行了数据提取和综合。应用了频繁主义图论模型和随机效应模型进行荟萃分析。
主要结果是急性 VCF 患者短期(4 周)活动时疼痛和长期(最新随访)非特定疼痛。
研究纳入了 20 项试验,共纳入 2102 名患者,评估了各种干预措施治疗 VCF。降钙素(标准化均数差 [SMD],-4.86;95%置信区间,-6.87 至 -2.86)和非甾体抗炎药(NSAIDs;SMD,-3.94;95%置信区间,-7.30 至 -0.58)与安慰剂相比,在短期活动时疼痛方面有益。对于长期非特异性疼痛管理,与每日(SMD,1.21;95%置信区间,0.11 至 2.31)或每周(SMD,1.13;95%置信区间,0.05 至 2.21)给予特立帕肽相比,双膦酸盐与较差的疼痛结局相关,没有一种治疗方法优于 NSAIDs。不良事件的定性分析强调了与这些药物相关的典型不良事件。
NSAIDs 和特立帕肽可能是急性骨质疏松性 VCF 疼痛管理的首选治疗选择。虽然降钙素也被证明是有益的,但它的安全性和潜在的不良反应限制了它的广泛应用。对支具和镇痛药的有限证据突出表明迫切需要开展未来的研究。